国家医保谈判引入“商保创新药目录”新机制，在完善我国多层次医疗保障体系的同时，为创新药打开更大市场空间。■夏金彪为期五天的国家医保谈判于11月3日收官，预计谈判结果于12月上旬发布。今年的国家医保谈判，在延续医保目录常规调整机制的基础上，首次引入商业健康保险创新药品目录(简称“商保创新药目录”)的新机制。新机制通过设立独立目录，纳入超出基本医保“保基本”定位但具有高创新性和显著临床价值的药品，推荐...
Source Link国家医保谈判引入“商保创新药目录”新机制，在完善我国多层次医疗保障体系的同时，为创新药打开更大市场空间。■夏金彪为期五天的国家医保谈判于11月3日收官，预计谈判结果于12月上旬发布。今年的国家医保谈判，在延续医保目录常规调整机制的基础上，首次引入商业健康保险创新药品目录(简称“商保创新药目录”)的新机制。新机制通过设立独立目录，纳入超出基本医保“保基本”定位但具有高创新性和显著临床价值的药品，推荐...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.